A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is Phase 1/2, multicenter, clinical study to evaluate the safety, efficacy, PK, and immunogenicity of IDE849 in subjects with DLL3-expressing tumors including SCLC.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Chęć udziału w badaniu i podpisanie zgody
- •Potwierdzony histologicznie lub cytologicznie rak płuca typu drobnokomórkowego lub inny nowotwór neuroendokrynny z markerem DLL3
- •Nowotwór pogorszył się lub wrócił po poprzednim leczeniu standardowym
- •Co najmniej jeden guz widoczny na badaniach obrazowych
- •Ogólny stan zdrowia pozwalający na uczestnictwo (skala ECOG 0-1)
- •Spodziewana długość życia ponad 3 miesiące
- •Prawidłowe wyniki badań krwi i funkcji narządów
- •Gotowość do pobrania próbek krwi i tkanki guza do badań
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (13)
Sarah Cannon Research Institute at HealthONE
Denver, United States
Sarah Cannon Research Institute at Florida Cancer Specialists
Orlando, United States
Fort Wayne Medical Oncology and Hematology, Inc. - Fort Wayne North Office
Fort Wayne, United States
START Midwest
Grand Rapids, United States
The Cancer and Hematology Centers
Grand Rapids, United States
Columbia University Medical Center - Herbert Irving Pavilion
New York, United States
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, United States
Sarah Cannon Research Institute - Oncology Partners
Nashville, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
Oncology Consultants, PA- Houston
Houston, United States
Next Oncology Dallas
Irving, United States
NEXT Oncology Virginia
Fairfax, United States
Swedish Cancer Institute
Seattle, United States
Trial contact
IDEAYA Clinical Trials
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.